| 000 | 02553nas a22003615i 4500 | ||
|---|---|---|---|
| 001 | 2365-421X | ||
| 003 | DE-He213 | ||
| 005 | 20260610082522.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150810s||||||||sz uu poo|||||| b|EN |d | ||
| 022 | _a2365-421X | ||
| 024 | 7 |
_a41181 _2local |
|
| 210 | 1 | 0 | _aEJNMMI radiopharm. chem. |
| 245 | 1 | 0 |
_aEJNMMI Radiopharmacy and Chemistry _h[electronic resource] / _cedited by Philip Elsinga. |
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer. |
|
| 300 | _bonline resource. | ||
| 520 | _aEJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists, biologists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel production methods of radionuclides, novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To foster daily practice in the community the journal stimulates submission regarding best practice and harmonization of methodologies. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers. To further serve the community the journal publishes abstracts of radiopharmaceutical-oriented congresses. . | ||
| 650 | 0 | _aNuclear medicine. | |
| 650 | 0 | _aImaging systems in biology. | |
| 650 | 0 | _aNuclear chemistry. | |
| 650 | 0 | _aTherapeutics. | |
| 650 | 0 | _aMedicine—Research. | |
| 650 | 0 | _aBiology—Research. | |
| 650 | 1 | 4 | _aNuclear Medicine. |
| 650 | 2 | 4 | _aBiological Imaging. |
| 650 | 2 | 4 | _aNuclear Chemistry. |
| 650 | 2 | 4 | _aTherapeutics. |
| 650 | 2 | 4 | _aBiomedical Research. |
| 700 | 1 |
_aElsinga, Philip. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 856 | 4 | 0 |
_uhttp://link.springer.com/journal/41181 _zOpen Access |
| 999 |
_c3658 _d3658 |
||